# Tapering of Biologics in Inflammatory Arthritis Patients in Remission

> **NCT04429776** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University of Manchester** · enrollment: 51 (actual)

## Conditions studied

- Rheumatoid Arthritis
- Psoriatic Arthritis

## Interventions

- **DIAGNOSTIC_TEST:** Drug level testing with feedback provided
- **DIAGNOSTIC_TEST:** Drug level testing with no feedback provided

## Key facts

- **NCT ID:** NCT04429776
- **Lead sponsor:** University of Manchester
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-05-13
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2024-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04429776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04429776, "Tapering of Biologics in Inflammatory Arthritis Patients in Remission". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04429776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*